Jim Simons Obs Eva Sa Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.83 $20,566 - $268,827	146,900 New	146,900 $21,000
Q1 2022 May 13, 2022	SELL	$1.1 - $2.17 $24,319 - $47,976	-22,109 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.99 - $3.1 $43,996 - $68,537	22,109 New	22,109 $44,000
Q3 2021 Nov 12, 2021	SELL	$2.47 - $3.34 $200,070 - $270,540	-81,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.56 - $3.35 $207,360 - $271,350	81,000 New	81,000 $245,000
Q1 2021 May 13, 2021	SELL	$2.01 - $5.05 $1.21 Million - $3.03 Million	-600,800 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.89 - $2.55 $1.14 Million - $1.53 Million	600,800 New	600,800 $1.25 Million
Q3 2020 Nov 13, 2020	SELL	$2.46 - $6.15 $544,890 - $1.36 Million	-221,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.01 - $5.95 $193,361 - $572,390	96,200 Added 76.78%	221,500 $1.31 Million
Q1 2020 May 14, 2020	SELL	$1.87 - $4.47 $184,756 - $441,636	-98,800 Reduced 44.09%	125,300 $302,000
Q4 2019 Feb 13, 2020	BUY	$2.48 - $8.1 $337,528 - $1.1 Million	136,100 Added 154.66%	224,100 $856,000
Q3 2019 Nov 13, 2019	BUY	$8.22 - $11.2 $69,048 - $94,080	8,400 Added 10.55%	88,000 $733,000
Q2 2019 Aug 12, 2019	BUY	$10.05 - $14.25 $56,280 - $79,800	5,600 Added 7.57%	79,600 $900,000
Q1 2019 May 14, 2019	BUY	$11.82 - $14.48 $108,744 - $133,216	9,200 Added 14.2%	74,000 $946,000
Q4 2018 Feb 13, 2019	BUY	$10.8 - $17.94 $699,840 - $1.16 Million	64,800 New	64,800 $820,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.